Circulating RNA levels poorly correlated with clinical progression in Huntington’s disease


  • Longitudinal changes in circulating RNA levels are only weakly correlated with disease progression in Huntington’s disease.

Why this matters

    More sensitive, robust and objective ways of monitoring Huntington’s disease progression are urgently needed to improve prognosis. This is the first longitudinal analysis in a single Huntington’s disease cohort to identify novel transcriptional Huntington’s disease biomarkers and test previously reported candidates. The findings suggest that circulating RNA levels are poor candidates as disease biomarkers.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.